フロリダ州における肺高血圧症の臨床試験
フロリダ州内の拠点で、肺高血圧症に関する12件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/11更新 · NCT07816185Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/02更新 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- 他3件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/13更新 · NCT07234032A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1相
18歳〜80歳 · 全性別 · 2026/07/31更新 · NCT06770023An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2026/06/26更新 · NCT06129240Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Shands at the University of Florida, Gainesville
- Cleveland Clinic Florida, Weston
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195Pulmonary Hypertension Association Registry
- Mayo Clinic Florida, Jacksonville
被験者募集中観察研究
0歳以上 · 全性別 · 2025/11/14更新 · NCT04071327ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。